SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling

被引:1
作者
La, Dan-yu [1 ]
Jiang, He-wei [1 ]
Li, Yang [2 ]
Zhang, Hai-nan [1 ]
Tao, Sheng-ce [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Minist Educ, Shanghai, Peoples R China
[2] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China
来源
STAR PROTOCOLS | 2022年 / 3卷 / 02期
基金
中国国家自然科学基金;
关键词
Biotechnology and bioengineering; Clinical Protocol; Health Sciences; Immunology; Protein Biochemistry; Protein expression and purification; Proteomics;
D O I
10.1016/j.xpro.2022.101238
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteome is largely unknown. Here we describe a protocol for analyzing sera samples with SARS-CoV-2 proteome microarray. The proteins were ex-pressed by either E. coli expression system or eukaryotic cell expression systems and obtained by affinity purification. The protocol includes microarray fabri-cating and sera profiling, which will be used to build an antibody response land-scape for IgG and IgM. The protocol may help to facilitate a deeper understand-ing of immunity related to SARS-CoV-2.For complete details on the use and execution of this protocol, please refer to Li et al. (2021c).
引用
收藏
页数:13
相关论文
共 5 条
  • [1] SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
    Jiang, He-wei
    Zhang, Hai-nan
    Meng, Qing-feng
    Xie, Jia
    Li, Yang
    Chen, Hong
    Zheng, Yun-xiao
    Wang, Xue-ning
    Qi, Huan
    Zhang, Jing
    Wang, Pei-Hui
    Han, Ze-Guang
    Tao, Sheng-ce
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (09) : 998 - 1000
  • [2] Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins
    Li, Yang
    Xu, Zhaowei
    Lei, Qing
    Lai, Dan-yun
    Hou, Hongyan
    Jiang, He-wei
    Zheng, Yun-xiao
    Wang, Xue-ning
    Wu, Jiaoxiang
    Ma, Ming-liang
    Zhang, Bo
    Chen, Hong
    Yu, Caizheng
    Xue, Jun-biao
    Zhang, Hai-nan
    Qi, Huan
    Guo, Shu-juan
    Zhang, Yandi
    Lin, Xiaosong
    Yao, Zongjie
    Sheng, Huiming
    Sun, Ziyong
    Wang, Feng
    Fan, Xionglin
    Tao, Sheng-ce
    [J]. CELL REPORTS, 2021, 36 (02):
  • [3] Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
    Li, Yang
    Ma, Ming-liang
    Lei, Qing
    Wang, Feng
    Hong, Wei
    Lai, Dan-yun
    Hou, Hongyan
    Xu, Zhao-wei
    Zhang, Bo
    Chen, Hong
    Yu, Caizheng
    Xue, Jun-biao
    Zheng, Yun-xiao
    Wang, Xue-ning
    Jiang, He-wei
    Zhang, Hai-nan
    Qi, Huan
    Guo, Shu-juan
    Zhang, Yandi
    Lin, Xiaosong
    Yao, Zongjie
    Wu, Jiaoxiang
    Sheng, Huiming
    Zhang, Yanan
    Wei, Hongping
    Sun, Ziyong
    Fan, Xionglin
    Tao, Sheng-ce
    [J]. CELL REPORTS, 2021, 34 (13):
  • [4] Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients
    Li, Yang
    Lai, Dan-yun
    Lei, Qing
    Xu, Zhao-wei
    Wang, Feng
    Hou, Hongyan
    Chen, Lingyun
    Wu, Jiaoxiang
    Ren, Yan
    Ma, Ming-liang
    Zhang, Bo
    Chen, Hong
    Yu, Caizheng
    Xue, Jun-biao
    Zheng, Yun-xiao
    Wang, Xue-ning
    Jiang, He-wei
    Zhang, Hai-nan
    Qi, Huan
    Guo, Shu-juan
    Zhang, Yandi
    Lin, Xiaosong
    Yao, Zongjie
    Pang, Pengfei
    Shi, Dawei
    Wang, Wei
    Yang, Xiao
    Zhou, Jie
    Sheng, Huiming
    Sun, Ziyong
    Shan, Hong
    Fan, Xionglin
    Tao, Sheng-ce
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (03) : 621 - 631
  • [5] Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
    Li, Yang
    Lai, Dan-yun
    Zhang, Hai-nan
    Jiang, He-wei
    Tian, Xiaolong
    Ma, Ming-liang
    Qi, Huan
    Meng, Qing-feng
    Guo, Shu-juan
    Wu, Yanling
    Wang, Wei
    Yang, Xiao
    Shi, Da-wei
    Dai, Jun-biao
    Ying, Tianlei
    Zhou, Jie
    Tao, Sheng-ce
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (10) : 1095 - 1097